Cancer: The red drink that ‘kills’ cancer cells and reduces tumour growth by up to 61%

Cancer patient says it took 10 hours to get home from hospital

We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info

Cancer occurs when damaged cells run rampant, spreading to other parts of the body. Fortunately, survival rates have significantly improved, owing to marked improvements in cancer care. Food intake holds great influence on one’s risk of developing cancer. One fruit, which contains a host of beneficial compounds with powerful anti-cancer properties, may be key for the prevention of cancer.

The medicinal properties of pomegranate have sparked great interest among medical circles in recent years.

This interest is largely attributed to studies that suggest the beneficial effects of pomegranate juice are greater than those of red wine or green tea.

Research into the anticancer activity of the fruit has unearthed a host of mechanisms shown to effectively prevent cancer.

Healthline states: “Pomegranates are juicy, sweet fruits that are particularly high in polyphenol antioxidants and nitrates, which are potent vasodilators.

READ MORE: Cancer symptoms: The ‘unpleasant’ sign of four cancers that may keep you up at night

What’s more, it may also shut off the ability of cancer cells to divide, according to the health body.

A paper published in the peer-reviewed journal Nutrition and Cancer summarises the protective effects of pomegranate juice observed in a host of studies.

In these animal studies, pomegranate was shown to reduce existing cancer cell growth and prevent blood vessel growth associated with tumours.

The authors cited research showing that fermented juice polyphenols from pomegranate result in 47 percent inhibition of cancerous lesion formation in mammals with breast cancer.

Similar findings showed that the juice can yield “significantly anti-proliferative and anti-tumour action against prostate cancer,” explained the authors.

During an investigation on lung cancer, mice treated with pomegranate fruit extract saw a tumour reduction of 61 percent in the pomegranate juice extract at 140 days, compared with those who didn’t.

“Tumours from these animals were examined for effects on cell proliferation and various signalling pathways,” explained the authors.

“These observations indicated the (PFE) could be used as a chemo-preventive / chemotherapeutic agent against human lung cancer.”

The inflammatory effects of PFE proved useful in colon cancer prevention too.

The authors added: “Inflammation plays a key role in the development of colon cancer and many anti-inflammatory agents have shown promise for prevention of colon cancer.

“These data suggest that polyphonic constituents in the pomegranate can play an important role in the modulation of inflammatory signalling in colon cancer cells.”

The data presents a strong case for the use of pomegranate against different types of cancer in both animals and humans.

Source: Read Full Article